Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Non-Small Cell Lung Cancer Metastatic 1Neurofibrosarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 6Radiotherapy 5selinexor 4pazopanib 3Sirolimus 3Ifosfamide 3AZD 6244 3pembrolizumab 2fludarabine phosphate 2Radiation Dose Hypofractionation 2Nivolumab 2Etoposide 2thymoglobulin 1temsirolimus 1tazemetostat 1sotigalimab 1ribociclib 1pexidartinib 1pegfilgrastim 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1ixazomib 1fludarabine 1decitabine and cedazuridine drug combination 1X-Rays 1Thiotepa 1Tacrolimus 1Surgical Procedures, Operative 1Sunitinib 1Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurofibrosarcoma × BO-112 × Clear all
NCT04420975 2026-03-10

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
14 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡